Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feld

Showing results (21-30 of 451) with videos related to

Pageof 46
Sort By:
Journal of Hepatology|February 16, 2021
Remaining challenges in HCV eliminationCamelia Capraru, Jordan J Feld
Gastroenterology|September 5, 2017
Risk for Hepatocellular Carcinoma After Hepatitis C Virus Antiviral Therapy With Direct-Acting Antivirals: Case Closed?Raoel Maan, Jordan J Feld
Alimentary Pharmacology & Therapeutics|February 6, 2014
Commentary: what factors are important in diagnosing hepatic fibrosis?M Kelley, J J Feld
Nature Reviews. Gastroenterology & Hepatology|May 6, 2016
Direct-acting antiviral agents for hepatitis C: structural and mechanistic insightsMatthias Götte, Jordan J Feld
Gut|February 20, 2016
One small SNP for receptor virus entry, one giant leap for hepatitis B?Neil Rajoriya, Jordan J Feld
Clinical Liver Disease|May 2, 2019
Defining and grading HBV reactivationAlissa Visram, Jordan J Feld
Alimentary Pharmacology & Therapeutics|August 23, 2013
Commentary: non-haemodynamic effects of beta-blockers in cirrhosis--more than meets the eye?S Sharma, J J Feld
Gastroenterology|December 24, 2013
Does eltrombopag really ENABLE SVR?Aviva Leber, Jordan J Feld
The New England Journal of Medicine|May 3, 2016
Sofosbuvir and Velpatasvir for Patients with HCV InfectionJordan J Feld, Stefan Zeuzem
Gastroenterology|May 1, 2026
Reply to Xu et al, Ni and Wang, Parikh and Singal, and Yang et alGrishma Hirode, Jordan J Feld
Pageof 46

Showing results (21-30 of 451) with videos related to

Sort By:
Pageof 46
Journal of Hepatology|February 16, 2021
Remaining challenges in HCV eliminationCamelia Capraru, Jordan J Feld
Gastroenterology|September 5, 2017
Risk for Hepatocellular Carcinoma After Hepatitis C Virus Antiviral Therapy With Direct-Acting Antivirals: Case Closed?Raoel Maan, Jordan J Feld
Alimentary Pharmacology & Therapeutics|February 6, 2014
Commentary: what factors are important in diagnosing hepatic fibrosis?M Kelley, J J Feld
Nature Reviews. Gastroenterology & Hepatology|May 6, 2016
Direct-acting antiviral agents for hepatitis C: structural and mechanistic insightsMatthias Götte, Jordan J Feld
Gut|February 20, 2016
One small SNP for receptor virus entry, one giant leap for hepatitis B?Neil Rajoriya, Jordan J Feld
Clinical Liver Disease|May 2, 2019
Defining and grading HBV reactivationAlissa Visram, Jordan J Feld
Alimentary Pharmacology & Therapeutics|August 23, 2013
Commentary: non-haemodynamic effects of beta-blockers in cirrhosis--more than meets the eye?S Sharma, J J Feld
Gastroenterology|December 24, 2013
Does eltrombopag really ENABLE SVR?Aviva Leber, Jordan J Feld
The New England Journal of Medicine|May 3, 2016
Sofosbuvir and Velpatasvir for Patients with HCV InfectionJordan J Feld, Stefan Zeuzem
Gastroenterology|May 1, 2026
Reply to Xu et al, Ni and Wang, Parikh and Singal, and Yang et alGrishma Hirode, Jordan J Feld
Pageof 46